Search Results:
CLINICAL TRIAL 18989
A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination with Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19327
A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases
Disease Site: Brain and Nervous System, Lung, Melanoma, skin, Melanoma, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 19407
An Open-Label, Randomized, Controlled Multi-Center Study of The Efficacy of Daromun (L19IL2 + L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery Versus Surgery Alone in Clinical Stage IIIB/C Melanoma Patients
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19441
Pilot Study of Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19475
Phase 1 Study of Trametinib + Ceritinib in Patients with Unresectable Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19480
The Reveal Study: A Phase 1/2, Open-Label, Multicenter, Dose Escalation And Dose Expansion Study Of Nktr-262 In Combination With Bempegaldesleukin (Nktr-214) And In combination With Bempegaldesleukin (Nktr-214) Plus Nivolumab In Patients With Locally Advanced Or Metastatic Solid Tumor Malignancies
Disease Site: Any Site, Bones and Joints, Breast, Colon, Corpus Uteri, Eye and Orbit, Lung, Melanoma, Skin - Do Not Use, Ovary, Soft Tissue, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 19754
A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19958
Phase I/II Study of Dabrafenib, Trametinib, and Navitoclax in BRAF Mutant Melanoma (Phase I and II) and Other Solid Tumors (Phase I only)
Disease Site: Bones and Joints, Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20162
Phase 1 Trial of Intralesional Immunotherapy with IFx-Hu2.0 Vaccine in Patients with Advanced Merkel Cell Carcinoma or Cutaneous Squamous Cell Carcinoma
Disease Site: Melanoma, skin, Other Skin, Merkel cell carcinoma (neuroendocrine skin cancer), Skin, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20313
Neoadjuvant Immunotherapy with Intratumoral Tavokinogene Telseplasmid (Tavo) plus Electroporation in Combination with Intravenous Nivolumab in Patients with Operable Locally- Regionally Advanced Melanoma
Disease Site: Melanoma, skin, Melanoma
View Trial DetailsCLINICAL TRIAL 20494
A Phase II Study of High Dose Bolus IL2 in Combination with Low Dose Ipilimumab Followed Sequentially by Nivolumab in Patients with Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20557
A Phase II, Open-Label, Multicenter, Randomized Study of Efficacy and Safety of RO7198457 in Combination with Pembrolizumab versus Pembrolizumab in Patients with Previously Untreated Advanced Melanoma
Disease Site: Melanoma, Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20641
A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20904
A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab vs Ipilimumab + Nivolumab in Braf-V600 Mutant Melanoma with Brain Metastases
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21061
An Examination of Patient Reported Outcomes and Predictors Among Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19733
Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility
Disease Site: Rectum, Other Female Genital, Urinary Bladder, Breast, Colon, Melanoma, skin, Bladder, Breast Cancer, Colorectal, Melanoma, Ovarian, Uterus, Vaginal, Vulva
View Trial Details